Study Comparing Two Methods for the Treatment of Large Chondral and Osteochondral Defects of the … (NCT05651997) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Study Comparing Two Methods for the Treatment of Large Chondral and Osteochondral Defects of the Knee
Switzerland80 participantsStarted 2026-12
Plain-language summary
The major objective of this study is to evaluate the efficacy of the MACT versus the AMT for the treatment of large cartilage defects in patellofemoral and femorotibial injuries.
Who can participate
Age range15 Years – 50 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients aged between 15-50 years
* Symptomatic chondral and osteochondral defect, grade III and IV according to the ICRS classification, and size between 2.5 and 15 cm2
* Failure of a conservative treatment
* Patient in good general condition, documented by an ASA score ≤ 2 (American Society of Anesthesiologists)
* Patient considered compliant and able to participate in rehabilitation and pre- and post-operative follow-up
* Consent to participate in the study
Exclusion Criteria:
* All inflammatory and synovial pathologies
* Diffuse or mirror lesions
* An unfavorable biomechanical environment
* Obesity grade II or higher, with a BMI\>35 kg/m2
* Active smoking/ active drug dependency (hard drugs)
* Poor compliance
* The patient is already part of another clinical trial that may compromise the present study
* Vulnerable populations (except minors aged 15-18 years)
* Presence of open growth plate (15-18 years)
* Pregnancy or planned pregnancy during the study (MRI-related contra-indication)
* Proven allergy to penicillin and gentamicin (for MACT group) and porcine collagen (for both groups)
For final inclusion, an additional exclusion criteria will be assessed after randomization:
\- Positive to HIV, HBV, HCV, syphilis.
What they're measuring
1
Patellofemoral joint-related function and quality-of-life are assessed using the Knee injury and Osteoarthritis Outcome Score (KOOS).
Timeframe: Change from baseline to 3, 6 12, 24, 36, 48 and 60 months post-implantation in the patellofemoral joint.